AMY CHEN: Open Payments
NPI 1821738444 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 23 payments from 10 companies in 2025. Trend: 2023 $266 · 2024 $614 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $148 |
| Corcept Therapeutics | 4 | $85 |
| Novo Nordisk Inc | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Lilly USA, LLC | 2 | $51 |
| Exact Sciences Corporation | 2 | $44 |
| ABBVIE INC. | 2 | $42 |
| SHIELD THERAPEUTICS INC | 2 | $37 |
| Amgen Inc. | 1 | $24 |
| Eisai Inc. | 1 | $18 |
Products named: XIFAXAN, Korlym, TRELEGY ELLIPTA, Ozempic, The Cologuard Plus Collection Kit, ACCRUFER, ZEPBOUND, REPATHA.
Industry payments across FL — which companies pay providers there.
